US Representative

Earl Carter 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 12)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4448

Introduced
6/30/23  
Canadian Snowbird Visa Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4468

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
Report Pass
7/27/23  
Choice in Automobile Retail Sales Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB448

Introduced
1/24/23  
Putting Investors First Act of 2023 This bill requires a proxy advisory firm to register with the Securities and Exchange Commission and prohibits an unregistered proxy advisory firm from using interstate commerce to provide proxy-voting advice, research, analysis, or recommendations to any client. With respect to these firms, the bill (1) establishes procedures for both registration and termination of registration; (2) requires each firm to employ an ombudsman, designate a compliance officer, and publicly disclose conflicts of interest; (3) allows issuers to assess and comment on proxy voting recommendations; and (4) prohibits unfair, coercive, or abusive practices. The bill establishes a private right of action against a proxy advisory firm that endorses an approved proposal that is not supported by the issuer and is found to be illegal.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4531

Introduced
7/11/23  
Refer
7/11/23  
Report Pass
7/19/23  
Report Pass
9/28/23  
Support for Patients and Communities Reauthorization Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4549

Introduced
7/11/23  
Refer
7/11/23  
Building Chips in America Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4563

Introduced
7/11/23  
Refer
7/11/23  
Refer
7/11/23  
ACE Act End Zuckerbucks Act of 2023 Solving an Overlooked Loophole in Votes for Executives (SOLVE) Act Promoting Free and Fair Elections Act Don't Weaponize the IRS Act American Confidence in Elections Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4587

Introduced
7/12/23  
Refer
7/12/23  
Refer
7/21/23  
Red Snapper Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB467

Introduced
1/24/23  
Refer
1/24/23  
Refer
1/24/23  
Report Pass
3/24/23  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4721

Introduced
7/18/23  
Main Street Tax Certainty Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4724

Introduced
7/18/23  
Sara’s Law and the Preventing Unfair Sentencing Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4739

Introduced
7/19/23  
Refer
7/19/23  
Protecting America’s Orchardists and Nursery Tree Growers Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4756

Introduced
7/19/23  
Community News and Small Business Support Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4758

Introduced
7/19/23  
Refer
7/19/23  
Refer
7/21/23  
Report Pass
6/12/24  
Accelerating Kids’ Access to Care Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB456

Introduced
1/24/23  
Refer
1/24/23  
Fairness in Orphan Drug Exclusivity Act This bill limits which orphan drugs may be granted a market exclusivity period by the Food and Drug Administration (FDA). (Generally, an orphan drug is one that is not economically viable because of the rarity of the disease that it treats; the sponsor of an FDA-designated orphan drug may be granted various incentives, such as a seven-year period in which the FDA may not grant market approval to a different sponsor for the same drug to treat the same disease.) Under this bill, if a drug is designated as an orphan drug on the basis that there is no reasonable expectation that the sponsor will recover the costs of developing and distributing the drug from U.S. sales, the drug shall be granted the seven-year exclusivity period only if the sponsor demonstrates that there is no reasonable expectation that it will recover such costs within its first 12 years of U.S. sales of the drug. When deciding whether an orphan drug meets this requirement, the FDA shall consider the sales of all drugs from the sponsor that are covered by the same orphan drug designation.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4605

Introduced
7/13/23  
Refer
7/13/23  
Healthy Moms and Babies Act